← All Sponsors
SPONSOR

European Organisation for Research and Treatment of Cancer - EORTC

Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Oligometastatic Squamous Cell Carcinoma of the Head and NeckProstate Cancer
NCT05815927 Phase 3
Recruiting

Pembrolizumab and Radiotherapy for Oligometastatic Head and Neck Cancer

Oligometastatic Squamous Cell Carcinoma of the Head and Neck
Belgium, Italy, Spain View Trial →
NCT05974774 Phase 3
Recruiting

Intermittent Androgen Deprivation Therapy in the Era of AR Pathway Inhibitors

Prostate Cancer
Denmark, France, Spain View Trial →